list of therapeutic monoclonal antibodies list of therapeutic monoclonal antibodies therapeutic, diagnostic and preventive monoclonal antibodies are clones of a single parent cell. when used as drugs, the international nonproprietary names (inns) end in -mab. the remaining syllables of the inns, as well as the column source, are explained in nomenclature of monoclonal antibodies. types of monoclonal antibodies with other structures than naturally occurring antibodies. the abbreviations in the column type are as follows: mab: whole monoclonal antibody fab: fragment, antigen-binding (one arm) f(ab')2: fragment, antigen-binding, including hinge region (both arms) fab': fragment, antigen-binding, including hinge region (one arm) variable fragments: scfv: single-chain variable fragment di-scfv: dimeric single-chain variable fragment sdab: single-domain antibody bsab: bispecific monoclonal antibody: 3funct: trifunctional antibody bite: bi-specific t-cell engager this list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column use does not necessarily indicate clinical usage. see the list of fda-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page. this is a dynamic list and may never be able to satisfy particular standards for completeness. you can help by adding missing items with reliable sources. namebrand nametypesourcetargetapproveduse 3f8mabmousegd2 gangliosideneuroblastoma abagovomabmabmouseca-125 (imitation)ovarian cancer abciximabreoprofabchimericcd41 (integrin alpha-iib)yplatelet aggregation inhibitor abituzumabmabhumanizedcd51cancer abrezekimabfabhumanizedil-13 abrilumabmabhumanintegrin α4 β7inflammatory bowel disease, ulcerative colitis, crohn's disease actoxumabmabhumanclostridium difficileclostridium difficile colitis adalimumabhumiramabhumantnf-αyrheumatoid arthritis, crohn's disease, plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, juvenile idiopathic arthritis, hemolytic disease of the newborn adecatumumabmabhumanepcamprostate and breast cancer aducanumabaduhelmmabhumanβ-amyloidyalzheimer's disease afasevikumabmabhumanil-17a, il-17fmultiple sclerosis afelimomabf(ab')2mousetnf-αsepsis alacizumab pegolf(ab')2humanizedvegfr2cancer alemtuzumablemtrada, campathmabhumanizedcd52ymultiple sclerosis alirocumabpraluentmabhumanpcsk9yhypercholesterolemia altumomab pentetatehybri-ceakermabmousecarcinoembryonic antigen (cea)colorectal cancer (diagnosis) amatuximabmabchimericmesothelincancer amivantamabrybrevantbsabhumanepidermal growth factor receptor (egfr), cmetynon-small cell lung cancer anatumomab mafenatoxfabmousetumor-associated glycoprotein 72 (tag-72)non-small cell lung cancer andecaliximabmabchimericgelatinase bgastric cancer or gastroesophageal junction adenocarcinoma anetumab ravtansinemabhumanmesothelin (msln)cancer anifrolumabsaphnelomabhumanifn-α/β receptorysystemic lupus erythematosus ansuvimabebangamabhumanebola virus glycoproteinytreatment of zaire ebolavirus (ebola virus) anrukinzumab(= ima-638)mabhumanizedil-13asthma apolizumabmabhumanizedhla-drhematological cancers aprutumab ixadotinmabhumanfgfr2 arcitumomabcea-scanfab'mousecarcinoembryonic antigen (cea)gastrointestinal cancers (diagnosis) ascrinvacumabmabhumanactivin receptor-like kinase 1cancer aselizumabmabhumanizedl-selectin (cd62l)severely injured patients atezolizumabtecentriqmabhumanizedpd-l1ycancer atidortoxumabmabhumanstaphylococcus aureus alpha toxin atinumabmabhumanrtn4 atoltivimabmabhumanpart of atoltivimab/maftivimab/odesivimab for treatment of zaire ebolavirus (ebola virus) atoltivimab/maftivimab/odesivimabinmazebmabhumanytreatment of zaire ebolavirus (ebola virus) atorolimumabmabhumanrhesus factorhemolytic disease of the newborn avelumabbavenciomabhumanpd-l1ycancer azintuxizumab vedotinmabchimeric/humanizedcd319cancer bamlanivimabmabhumanspike protein receptor binding domain (rbd) of sars-cov-2emergency use authorization (eua) when used with etesevimabcovid-19 bapineuzumabmabhumanizedβ-amyloidalzheimer's disease basiliximabsimulectmabchimericcd25 (α chain of il-2 receptor)yprevention of organ transplant rejections bavituximabmabchimericphosphatidylserinecancer, viral infections bcd-100humanpd-1melanoma bebtelovimabmabhumanspike protein receptor binding domain (rbd) of sars-cov-2emergency use authorization (eua)covid-19 bectumomablymphoscanfab'mousecd22non-hodgkin's lymphoma (detection) bedinvetmablibrelamabveterinarynerve growth factor (ngf)ypain associated with osteoarthritis in dogs begelomabmabmousedpp4 belantamab mafodotinblenrepmabhumanizedb-cell maturation antigen (bcma)yrelapsed or refractory multiple myeloma belimumabbenlystamabhumanb-cell activating factor (baff)ysystemic lupus erythematosus without renal or cns involvement bemarituzumabmabhumanizedfgfr2gastric cancer or gastroesophageal junction adenocarcinoma benralizumabfasenramabhumanizedcd125yasthma berlimatoxumabmabhumanstaphylococcus aureus bi-component leukocidin bermekimabxilonixmabhumanil-1αcolorectal cancer bersanlimabmabhumanicam-1 bertilimumabmabhumanccl11 (eotaxin-1)severe allergic disorders besilesomabscintimunmabmousecarcinoembryonic antigen (cea)-related antigeninflammatory lesions and metastases (detection) bevacizumabavastinmabhumanizedvegf-aymetastatic cancer, retinopathy of prematurity bezlotoxumabzinplavamabhumanclostridium difficileyclostridium difficile colitis biciromabfibriscintfab'mousefibrin ii, beta chainthromboembolism (diagnosis) bimagrumabmabhumanacvr2bmyostatin inhibitor bimekizumabbimzelxmabhumanizedil-17a, il-17f, il-17afypsoriasis birtamimabmabchimericserum amyloid a proteinamyloidosis bivatuzumabmabhumanizedcd44 v6squamous cell carcinoma bleselumabmabhumancd40organ transplant rejection blinatumomabblincytobitemousecd19ypre-b acute lymphoblastic leukemia (all) (cd19+) blontuvetmabblontressmabveterinarycd20 blosozumabmabhumanizedsostosteoporosis bococizumabmabhumanizedpcsk9dyslipidemia brazikumabmabhumanil-23crohn's disease brentuximab vedotinadcentrismabchimericcd30 (tnfrsf8)yhodgkin's lymphoma, anaplastic large-cell lymphoma briakinumabmabhumanil-12, il-23psoriasis, rheumatoid arthritis, inflammatory bowel diseases, multiple sclerosis brodalumabsiliqmabhumanil-17yplaque psoriasis brolucizumabbeovuscfvhumanizedvascular endothelial growth factor a (vegfa)ywet age-related macular degeneration brontictuzumabmabhumanizednotch 1cancer burosumabcrysvitamabhumanfgf 23yx-linked hypophosphatemia cabiralizumabmabhumanizedcsf1rmetastatic pancreatic cancer camidanlumab tesirinemabhumancd25 (α chain of il-2 receptor)b-cell hodgkin's lymphoma, non-hodgkin lymphoma, acute lymphoblastic leukemia, acute myeloid leukemia camrelizumabmabhumanizedpd-1hepatocellular carcinoma canakinumabilarismabhumanil-1ycryopyrin-associated periodic syndrome cantuzumab mertansinemabhumanizedcanag (a glycoform of muc1)colorectal cancer etc. cantuzumab ravtansinemabhumanizedcanag (a glycoform of muc1)cancers caplacizumabcablivisdabhumanizedvwfythrombotic thrombocytopenic purpura, thrombosis casirivimabmabhumanspike protein receptor binding domain (rbd) of sars-cov-2yes when used with imdevimabcovid-19 capromabprostascintmabmouseglutamate carboxypeptidase iiyprostate cancer (detection) carlumabmabhumanmcp-1oncology/immune indications carotuximabmabchimericendoglinangiosarcoma catumaxomabremovab3functrat/mouse hybridepcam, cd3yovarian cancer, malignant ascites, gastric cancer cbr96-doxorubicin immunoconjugatemabhumanizedlewis-y antigencancer cedelizumabmabhumanizedcd4prevention of organ transplant rejections, treatment of autoimmune diseases cemiplimablibtayomabhumanpd-1ycutaneous squamous cell carcinoma cergutuzumab amunaleukinmabhumanizedil-2cancer certolizumab pegolcimziafab'humanizedtnf-αycrohn's disease, rheumatoid arthritis, axial spondyloarthritis, psoriasis arthritis cetrelimabmabhumanpd-1cancer cetuximaberbituxmabchimericepidermal growth factor receptor (egfr)ymetastatic colorectal cancer and head and neck cancer cibisatamabmabhumanizedceacam5cancer cilgavimabmabhumanspike protein receptor binding domain (rbd) of sars-cov-2emergency use authorization (eua) when used with tixagevimabcovid-19 cirmtuzumabhumanizedror1chronic lymphocytic leukemia citatuzumab bogatoxfabhumanizedepcamovarian cancer and other solid tumors cixutumumabmabhumanigf-1 receptor (cd221)solid tumors clazakizumabmabhumanizedil-6rheumatoid arthritis clenoliximabmabchimericcd4rheumatoid arthritis clivatuzumab tetraxetanhpam4-cidemabhumanizedmuc1pancreatic cancer codrituzumabmabhumanizedglypican 3cancer cofetuzumab pelidotinmabhumanizedptk7cancer coltuximab ravtansinemabchimericcd19cancer conatumumabmabhumantrail-r2cancer concizumabmabhumanizedtissue factor pathway inhibitor (tfpi)bleeding cosfroviximabzmappmabchimericebolavirus glycoproteinebola virus crenezumabmabhumanizedβ-amyloid (1-40 and 1-42)alzheimer's disease crizanlizumabadakveomabhumanizedselectin pysickle-cell disease crotedumabmabhumanglucagon receptor (gcgr)diabetes cr6261mabhumanhemagglutinin (influenza)infectious disease/influenza a cusatuzumabmabhumanizedcd70cancer dacetuzumabmabhumanizedcd40hematologic cancers daclizumabzenapaxmabhumanizedcd25 (α chain of il-2 receptor)yprevention of organ transplant rejections, multiple sclerosis dalotuzumabmabhumanizedigf-1 receptor (cd221)cancer etc. dapirolizumab pegolmabhumanizedcd154 (cd40l) daratumumabdarzalexmabhumancd38ymultiple myeloma dectrekumabmabhumanil-13 demcizumabmabhumanizeddll4cancer denintuzumab mafodotinmabhumanizedcd19cancer denosumabproliamabhumanranklyosteoporosis, bone metastases etc. depatuxizumab mafodotinmabchimeric/humanizedegfrglioblastoma derlotuximab biotinmabchimerichistone complexrecurrent glioblastoma multiforme detumomabmabmouseb-lymphoma celllymphoma dezamizumabmabhumanizedserum amyloid p component dinutuximabunituxinmabchimericgd2 gangliosideyneuroblastoma dinutuximab betaqarzibamabchimericgd2 gangliosideyneuroblastoma diridavumabmabhumanhemagglutinin (influenza)influenza a domagrozumabmabhumanizedgdf-8duchenne muscular dystrophy dorlimomab aritoxf(ab')2mouse dostarlimabjemperlimabhumanizedpcdp1yendometrial cancer drozitumabmabhumandr5cancer etc. ds-8201humanizedher2gastric or gastroesophageal junction adenocarcinoma duligotuzumabmabhumanizederbb3 (her3)testicular cancer dupilumabdupixentmabhumanil-4rαyatopic dermatitis, asthma, nasal polyps durvalumabimfinzimabhumanpd-l1ycancer dusigitumabmabhumanigf-2b-cell malignancies duvortuxizumabscfvchimeric/humanizedcd19, cd3ecancer ecromeximabmabchimericgd3 gangliosidemalignant melanoma eculizumabsolirismabhumanizedc5yparoxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome edobacomabmabmouseendotoxinsepsis caused by gram-negative bacteria edrecolomabpanorexmabmouseepcamcolorectal carcinoma efalizumabraptivamabhumanizedlfa-1 (cd11a)psoriasis (blocks t-cell migration) efungumabmycograbscfvhumanhsp90invasive candida infection eldelumabmabhumancxcl10 (ip-10)crohn's disease, ulcerative colitis elezanumabmabhumanrepulsive guidance molecule a (rgma)spinal cord injury and multiple sclerosis elgemtumabmabhumanerbb3 (her3)cancer elotuzumabemplicitimabhumanizedslamf7ymultiple myeloma elsilimomabmabmouseil-6 emactuzumabmabhumanizedcsf1rcancer emapalumabgamifantmabhumanifn-γyhemophagocytic lymphohistiocytosis emibetuzumabmabhumanizedhgfrcancer emicizumabhemlibrabsabhumanizedactivated f9, f10yhaemophilia a enapotamab vedotinmabhumanaxlcancer enavatuzumabmabhumanizedtweak receptorcancer etc. enfortumab vedotinpadcevmabhumannectin-4yurothelial cancer enlimomab pegolmabmouseicam-1 (cd54) enoblituzumabmabhumanizedcd276cancer enokizumabmabhumanizedil-9asthma enoticumabmabhumandll4 ensituximabmabchimericmuc5accancer epcoritamabbsabhumancd3, cd20b-cell lymphoma epitumomab cituxetanmabmouseepisialin epratuzumabmabhumanizedcd22cancer, systemic lupus erythematosus (sle) eptinezumabvyeptimabhumanizedcalcitonin gene-related peptideymigraine erenumabaimovigmabhumancalcitonin gene-related peptide receptor (cgrp)ymigraine erlizumabf(ab')2humanizeditgb2 (cd18)heart attack, stroke, traumatic shock ertumaxomabrexomun3functrat/mouse hybridher2/neu, cd3ybreast cancer etc. etaracizumababegrinmabhumanizedintegrin αvβ3ymelanoma, prostate cancer, ovarian cancer etc. etesevimabmabhumanspike protein receptor binding domain (rbd) of sars-cov-2emergency use authorization (eua) when used with bamlanivimabcovid-19 etigilimabmabhumanizedtigit etrolizumabmabhumanizedintegrin β7inflammatory bowel disease evinacumabevkeezamabhumanangiopoietin 3ydyslipidemia evolocumabrepathamabhumanpcsk9yhypercholesterolemia exbivirumabmabhumanhepatitis b surface antigenhepatitis b fanolesomabneutrospecmabmousecd15appendicitis (diagnosis) faralimomabmabmouseifn receptor faricimabvabysmomabhumanizedvegf-a and ang-2yangiogenesis, ocular vascular diseases farletuzumabmabhumanizedfolate receptor 1ovarian cancer fasinumabmabhumannerve growth factor (ngf)acute sciatic pain fbta05lymphomun3functrat/mouse hybridcd20chronic lymphocytic leukaemia felvizumabmabhumanizedrespiratory syncytial virusrespiratory syncytial virus infection fezakinumabmabhumanil-22rheumatoid arthritis, psoriasis fibatuzumabmabhumanizedephrin receptor a3 ficlatuzumabmabhumanizedhepatocyte growth factor (hgf)cancer etc. figitumumabmabhumanigf-1 receptor (cd221)adrenocortical carcinoma, non-small cell lung carcinoma etc. firivumabmabhumanhemagglutinin (influenza) flanvotumabmabhumantyrp1 (glycoprotein 75)melanoma fletikumabmabhumanil-20rheumatoid arthritis flotetuzumabdi-scfvhumanizedil-3 receptorhematological malignancies fontolizumabhuzafmabhumanizedifn-γcrohn's disease etc. foralumabmabhumancd3e foravirumabmabhumanrabies virus glycoproteinrabies (prophylaxis) fremanezumabajovymabhumanizedcalcitonin gene-related peptide alpha and betaymigraine fresolimumabmabhumantgf-βidiopathic pulmonary fibrosis, focal segmental glomerulosclerosis, cancer frovocimabmabhumanizedpcsk9hypercholesterolemia frunevetmabsolensiamabveterinarynerve growth factor (ngf)ypain associated with osteoarthritis in cats fulranumabmabhumannerve growth factor (ngf)pain futuximabmabchimericepidermal growth factor receptor (egfr)cancer galcanezumabemgalitymabhumanizedcalcitoninymigraine galiximabmabchimericcd80b-cell lymphoma gancotamabscfvhumanher2/neucancer ganitumabmabhumanigf-1 receptor (cd221)cancer gantenerumabmabhumanβ-amyloid (1-40 and 1-42)alzheimer's disease gatipotuzumabmabhumanizedmuc1cancer gavilimomabmabmousecd147 (basigin)graft versus host disease gedivumabmabhumanhemagglutinin (influenza) gemtuzumab ozogamicinmylotargmabhumanizedcd33yacute myelogenous leukemia gevokizumabmabhumanizedil-1βdiabetes etc. gilvetmabmabveterinarypcdc1 gimsilumabmabhumancsf2rheumatoid arthritis girentuximabrencarexmabchimericcarbonic anhydrase 9 (ca-ix)clear cell renal cell carcinoma glembatumumab vedotinmabhumangpnmbmelanoma, breast cancer glofitamabcolumvibsabhumanizedcd20, cd3ydiffuse large b-cell lymphoma golimumabsimponimabhumantnf-αyrheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis gomiliximabmabchimericcd23 (ige receptor)allergic asthma gosuranemabmabhumanizedtau proteinprogressive supranuclear palsy guselkumabtremfyamabhumanil-23ypsoriasis ianalumabmabhumanbaff-rautoimmune hepatitis ibalizumabtrogarzomabhumanizedcd4yhiv infection sintilimabhumanpd-1squamous cell non-small cell lung cancer ibritumomab tiuxetanzevalinmabmousecd20ynon-hodgkin's lymphoma icrucumabmabhumanvegfr-1cancer etc. idarucizumabpraxbindmabhumanizeddabigatranyreversal of anticoagulant effects of dabigatran ifabotuzumabmabhumanizedepha3glioblastoma multiforme igovomabindimacis-125f(ab')2mouseca-125ovarian cancer (diagnosis) iladatuzumab vedotinmabhumanizedcd79bcancer imalumabmabhumanmacrophage migration inhibitory factor (mif)cancer imaprelimabmabhumanizedmelanoma cell adhesion molecule (mcam) imciromabmyoscintmabmousecardiac myosinycardiac imaging imdevimabmabhumanspike protein receptor binding domain (rbd) of sars-cov-2yes when used with casirivimabcovid-19 imgatuzumabmabhumanizedepidermal growth factor receptor (egfr)cancer inclacumabmabhumanselectin pcardiovascular disease indatuximab ravtansinemabchimericsdc1cancer indusatumab vedotinmabhumangucy2ccancer inebilizumabupliznamabhumanizedcd19ycancer, systemic sclerosis, multiple sclerosis infliximabremicademabchimerictnf-αyrheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis, crohn's disease, ulcerative colitis intetumumabmabhumancd51solid tumors (prostate cancer, melanoma) inolimomabmabmousecd25 (α chain of il-2 receptor)graft versus host disease inotuzumab ozogamicinbesponsamabhumanizedcd22yacute lymphoblastic leukemia (all) ipilimumabyervoymabhumancd152ymelanoma iomab-bmousecd45ablation of bone marrow iratumumabmabhumancd30 (tnfrsf8)hodgkin's lymphoma isatuximabsarclisamabchimericcd38ymultiple myeloma iscalimabmabhumancd40 istiratumabmabhumanigf-1 receptor (cd221)advanced solid tumors itolizumabalzumabmabhumanizedcd6ypsoriasis ixekizumabtaltzmabhumanizedil-17ayautoimmune diseases keliximabmabchimericcd4chronic asthma labetuzumabcea-cidemabhumanizedcarcinoembryonic antigen (cea)colorectal cancer lacnotuzumabmabhumanizedcsf1, macrophage colony stimulating factor (mcsf)cancer ladiratuzumab vedotinmabhumanizedliv-1cancer lampalizumabfabhumanizedcomplement factor d (cfd)geographic atrophy secondary to age-related macular degeneration lanadelumabtakhzyromabhumankallikreinyangioedema landogrozumabmabhumanizedgdf-8muscle wasting disorders laprituximab emtansinemabchimericepidermal growth factor receptor (egfr) larcaviximabmabchimericebolavirus glycoproteinebola virus lebrikizumabmabhumanizedil-13asthma lecanemableqembimabhumanizedβ-amyloidyalzheimer's disease lemalesomabmabmousenca-90 (granulocyte antigen)diagnostic agent lendalizumabmabhumanizedc5 lenvervimabmabhumanizedhepatitis b surfage antigenhepatitis b lenzilumabmabhumancsf2chronic myelomonocytic leukemia and juvenile myelomonocytic leukemia lerdelimumabmabhumantgf-β2reduction of scarring after glaucoma surgery leronlimabmabhumanizedccr5breast cancer, hiv lesofavumabmabhumanhemagglutinin (influenza) letolizumabscfvhumanizedtumor necrosis factor related activation protein (trap)inflammatory diseases lexatumumabmabhumantrail-r2cancer libivirumabmabhumanhepatitis b surface antigenhepatitis b lifastuzumab vedotinmabhumanizedphosphate-sodium co-transportercancer ligelizumabmabhumanizedighesevere asthma and chronic spontaneous urticaria loncastuximab tesirinezynlontamabchimericcd19yrelapsed or refractory large b-cell lymphoma losatuxizumab vedotinmabchimeric/humanizedepidermal growth receptor factor (egrf), erbb1 her1cancer lilotomab satetraxetanmabmousecd37cancer lintuzumabmabhumanizedcd33cancer lirilumabmabhumankir2dsolid and hematological cancers lodelcizumabmabhumanizedpcsk9hypercholesterolemia lokivetmabcytopointmabveterinarycanis lupus familiaris il31yclinical signs of atopic dermatitis in dogs lorvotuzumab mertansinemabhumanizedcd56cancer lucatumumabmabhumancd40multiple myeloma, non-hodgkin's lymphoma, hodgkin's lymphoma lulizumab pegolmabhumanizedcd28autoimmune diseases lumiliximabmabchimericcd23 (ige receptor)chronic lymphocytic leukemia lumretuzumabmabhumanizederbb3 (her3)cancer lupartumabmabhuman lupartumab amadotinmabhumanlypd3 lutikizumabmabhumanizedil-1α maftivimabmabhumanpart of atoltivimab/maftivimab/odesivimab for treatment of zaire ebolavirus (ebola virus) mapatumumabmabhumantrail-r1cancer margetuximabmargenzamabhumanizedher2ybreast cancer marstacimabmabhumantissue factor pathway inhibitor (tfpi)bleeding with hemophilia maslimomabmouset-cell receptor mavrilimumabmabhumangmcsf receptor α-chainrheumatoid arthritis matuzumabmabhumanizedepidermal growth factor receptor (egfr)colorectal, lung and stomach cancer mepolizumabbosatriamabhumanizedil-5yasthma and white blood cell diseases metelimumabmabhumantgf-β1systemic scleroderma milatuzumabmabhumanizedcd74multiple myeloma and other hematological malignancies minretumomabmabmousetag-72tumor detection (and therapy?) mirikizumabmabhumanizedil-23apsoriasis mirvetuximab soravtansineelaheremabchimericfolate receptor alphayovarian cancer mitumomabmabmousegd3 gangliosidesmall cell lung carcinoma modotuximabmabchimericegfr extracellular domain iiicancer mogamulizumabpoteligeomabhumanizedccr4yadult t-cell leukemia/lymphoma monalizumabmabhumanizednkg2arheumatoid arthritis, gynecologic malignancies, and other cancers morolimumabmabhumanrhesus factor mosunetuzumablunsumiobitehumanizedcd3e, ms4a1, cd20yfollicular lymphoma motavizumabnumaxmabhumanizedrespiratory syncytial virusrespiratory syncytial virus (prevention) moxetumomab pasudotoxlumoxitimabmousecd22yhairy cell leukemia muromonab-cd3orthoclone okt3mabmousecd3prevention of organ transplant rejections nacolomab tafenatoxfabmousec242 antigencolorectal cancer namilumabmabhumancsf2 naptumomab estafenatoxfabmouse5t4non-small cell lung carcinoma, renal cell carcinoma naratuximab emtansinemabchimericcd37 narnatumabmabhumanmst1r (aka ron)cancer natalizumabtysabrimabhumanizedintegrin α4ymultiple sclerosis, crohn's disease navicixizumabmabchimeric/humanizeddll4 and vegfacancer navivumabmabhumanhemagglutinin (influenza) naxitamabdanyelzahumanizedc-metyhigh-risk neuroblastoma and refractory osteomedullary disease nebacumabmabhumanendotoxinsepsis necitumumabportrazzamabhumanepidermal growth factor receptor (egfr)ynon-small cell lung carcinoma nemolizumabmabhumanizedil-31 receptor aeczema neod001humanizedamyloidprimary systemic amyloidosis nerelimomabmabmousetnf-α nesvacumabmabhumanangiopoietin 2cancer netakimabefleiramabchimericil-17aplaque psoriasis nimotuzumabbiomab-egfr, theracim, theralocmabhumanizedepidermal growth factor receptor (egfr)ysquamous cell carcinoma, head and neck cancer, nasopharyngeal cancer, glioma nirsevimabmabhumanrsv fusion glycoproteinrespiratory syncytial virus nivolumabopdivomabhumanpd-1ycancer nofetumomab merpentanverlumafabmousecancer (diagnosis) obiltoxaximabanthimmabchimericbacillus anthracis anthraxybacillus anthracis spores obinutuzumabgazyvamabhumanizedcd20ychronic lymphatic leukemia ocaratuzumabmabhumanizedcd20cancer ocrelizumabocrevusmabhumanizedcd20ymultiple sclerosis odesivimabmabhumanpart of atoltivimab/maftivimab/odesivimab for treatment of zaire ebolavirus (ebola virus) odulimomabmabmouselfa-1 (cd11a)prevention of organ transplant rejections, immunological diseases ofatumumabarzerra, kesimptamabhumancd20ychronic lymphocytic leukemia, multiple sclerosis olaratumablartruvomabhumanpdgfraycancer oleclumabmabhuman5'-nucleotidasepancreatic and colorectal cancer olendalizumabmabhumanizedcomplement c5asystemic lupus erythematosus, lupus nephritis, acute graft-versus-hose disease olokizumabmabhumanizedil-6rheumatoid arthritis omalizumabxolairmabhumanizedige fc regionyallergic asthma omburtamabmabmousecd276cancer oms721humanmasp-2atypical hemolytic uremic syndrome onartuzumabfabhumanizedhuman scatter factor receptor kinasecancer ontuxizumabmabchimeric/humanizedtem1cancer onvatilimabmabhumanvista (protein) (vsir) opicinumabmabhumanlingo-1multiple sclerosis oportuzumab monatoxviciniumscfvhumanizedepcambladder cancer oregovomabovarexmabmouseca-125ovarian cancer orticumabmabhumanoxldl otelixizumabmabchimeric/humanizedcd3diabetes mellitus type 1 otilimabmabhumangmcsfosteoarthritis, rheumatoid arthritis otlertuzumabmabhumanizedcd37cancer oxelumabmabhumanox-40asthma ozanezumabmabhumanizednogo-aals and multiple sclerosis ozoralizumabmabhumanizedtnf-αinflammation pagibaximabmabchimericlipoteichoic acidsepsis (staphylococcus) palivizumabsynagis, abbosynagismabhumanizedf protein of respiratory syncytial virusyrespiratory syncytial virus (prevention) pamrevlumabmabhumanconnective tissue growth factor (ctgf)idiopathic pulmonary fibrosis (ipf), pancreatic cancer panitumumabvectibixmabhumanepidermal growth factor receptor (egfr)ycolorectal cancer pankomabmabhumanizedtumor specific glycosylation of muc1ovarian cancer panobacumabmabhumanpseudomonas aeruginosapseudomonas aeruginosa infection parsatuzumabmabhumanizedegfl7cancer pascolizumabmabhumanizedil-4asthma pasotuxizumabmabchimeric/humanizedfolate hydrolasecancer pateclizumabmabhumanizedlymphotoxin alpha (lta)tnf patritumabmabhumanerbb3 (her3)cancer pdr001humanizedpd-1melanoma pembrolizumabkeytrudamabhumanizedpd-1ymelanoma and other cancers pemtumomabtheragynmousemuc1cancer perakizumabmabhumanizedil-17aarthritis pertuzumabperjetamabhumanizedher2/neuycancer pexelizumabscfvhumanizedc5reduction of side effects of cardiac surgery pidilizumabmabhumanizedpd-1cancer and infectious diseases pinatuzumab vedotinmabhumanizedcd22cancer pintumomabmabmouseadenocarcinoma antigenadenocarcinoma (imaging) placulumabmabhumantnfpain and inflammatory diseases prezalumabmabhumantnf plozalizumabmabhumanizedccr2diabetic nephropathy and arteriovenous graft patency pogalizumabmabhumanizedtumor necrosis factor receptor (tnfr) superfamily member 4 polatuzumab vedotinpolivymabhumanizedcd79bydiffuse large b-cell lymphoma ponezumabmabhumanizedβ-amyloidalzheimer's disease porgaviximabmabchimericzaire ebolavirus glycoproteinebola virus disease prasinezumabmabhumanizedalpha-synucleinparkinson's disease prezalizumabmabhumanizedinducible t-cell co-stimulatory ligand (icosl) priliximabmabchimericcd4crohn's disease, multiple sclerosis pritoxaximabmabchimerice. coli shiga toxin type-1 pritumumabmabhumanvimentinbrain cancer pro 140humanizedccr5hiv infection quilizumabmabhumanizedigheasthma racotumomabvaxiramabmousengna gangliosideynon-small cell lung cancer radretumabmabhumanfibronectin extra domain-bcancer rafivirumabmabhumanrabies virus glycoproteinrabies (prophylaxis) ralpancizumabmabhumanizedpcsk9dyslipidemia ramucirumabcyramzamabhumanvegfr2ysolid tumors ranevetmabmabveterinaryngfosteoarthritis in dogs ranibizumablucentisfabhumanizedvegf-aymacular degeneration (wet form) raxibacumabmabhumananthrax toxin, protective antigenyanthrax (prophylaxis and treatment) ravagalimabmabhumanizedcd40crohn's disease ravulizumabultomirismabhumanizedc5yparoxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome refanezumabmabhumanizedmyelin-associated glycoproteinrecovery of motor function after stroke regavirumabmabhumancytomegalovirus glycoprotein bcytomegalovirus infection regdanvimabregkironamabhumanspike protein receptor binding domain (rbd) of sars-cov-2ycovid-19 relatlimabmabhumanlag3melanoma remtolumabmabhumanil-17a, tnf reslizumabcinqairmabhumanizedil-5yinflammations of the airways, skin and gastrointestinal tract retifanlimabzynyzmabhumanizedpd-1ymerkel cell carcinoma rilotumumabmabhumanhepatocyte growth factor (hgf)solid tumors rinucumabmabhumanpdgfrbneovascular age-related macular degeneration risankizumabskyrizimabhumanizedil-23aycrohn's disease, psoriasis, psoriatic arthritis, and asthma rituximabmabthera, rituxanmabchimericcd20ylymphomas, leukemias, some autoimmune disorders rivabazumab pegolmabhumanizedpseudomonas aeruginosa type iii secretion system robatumumabmabhumanigf-1 receptor (cd221)cancer rmabrabishieldhumanrabies virus g glycoproteinypost-exposure prophylaxis of rabies roledumabmabhumanrhd (gene) (rhd)rh disease romilkimabmabchimeric/humanizedil-13 romosozumabevenitymabhumanizedsclerostinyosteoporosis rontalizumabmabhumanizedifn-αsystemic lupus erythematosus rosmantuzumabmabhumanizedroot plate-specific spondin 3cancer rovalpituzumab tesirinemabhumanizeddll3small cell lung cancer rovelizumableukarrestmabhumanizedcd11, cd18yhaemorrhagic shock etc. rozanolixizumabmabchimeric/humanizedfcgrtimmune thrombocytopenic purpura (itp), myasthenia gravis ruplizumabantovamabhumanizedcd154 (cd40l)yrheumatic diseases sa237humanizedil-6 receptorneuromyelitis optica and neuromyelitis optica spectrum disorders sacituzumab govitecantrodelvymabhumanizedtrop-2ytriple-negative breast cancer samalizumabmabhumanizedcd200cancer samrotamab vedotinmabchimeric/humanizedlrrc15cancer sarilumabkevzaramabhumanil-6yrheumatoid arthritis, ankylosing spondylitis satralizumabenspryngmabhumanizedil-6 receptoryneuromyelitis optica satumomab pendetidemabmousetag-72cancer (diagnosis) secukinumabcosentyxmabhumanil-17ayuveitis, rheumatoid arthritis psoriasis selicrelumabmabhumancd40 seribantumabmabhumanerbb3 (her3)cancer setoxaximabmabchimerice. coli shiga toxin type-2 setrusumabmabhumansclerostin (sost) sevirumabhumancytomegaloviruscytomegalovirus infection sibrotuzumabmabhumanizedfap (gene) (fap)cancer sgn-cd19amabhumanizedcd19acute lymphoblastic leukemia and b-cell non-hodgkin lymphoma shp647humanmucosal addressin cell adhesion moleculecrohn's disease sifalimumabmabhumanifn-αsystemic lupus erythematosus (sle), dermatomyositis, polymyositis siltuximabsylvantmabchimericil-6ycancer simtuzumabmabhumanizedloxl2fibrosis siplizumabmabhumanizedcd2psoriasis, graft-versus-host disease (prevention) sirtratumab vedotinmabhumanslitrk6cancer sirukumabmabhumanil-6rheumatoid arthritis sofituzumab vedotinmabhumanizedca-125ovarian cancer solanezumabmabhumanizedβ-amyloidalzheimer's disease solitomabbitemouseepcamgastrointestinal, lung, and other cancers sonepcizumabhumanizedsphingosine-1-phosphatechoroidal and retinal neovascularization sontuzumabmabhumanizedepisialin sotrovimabxevudymabhumanspike protein receptor binding domain (rbd) of sars-cov-2ycovid-19 spartalizumabmabhumanizedpd-1melanoma spesolimabspevigomabhumanizedinterleukin 36 receptor (il1rl2/il1rap)ygeneralized pustular psoriasis (gpp) stamulumabmabhumanmyostatinmuscular dystrophy sulesomableukoscanfab'mousenca-90 (granulocyte antigen)osteomyelitis (imaging) suptavumabmabhumanrsvfrmedically attended lower respiratory disease sutimlimabenjaymomabchimeric/humanizedcomplement component 1s (c1s)ycold agglutinin disease suvizumabmabhumanizedhiv-1viral infections suvratoxumabmabhumanstaphylococcus aureus alpha toxinnosocomial pneumonia tabalumabmabhumanb-cell activating factor (baff)b-cell cancers tacatuzumab tetraxetanafp-cidemabhumanizedalpha-fetoproteincancer tadocizumabfabhumanizedintegrin αiibβ3percutaneous coronary intervention tafasitamabmonjuvimabhumanized(from mouse)cd19yrelapsed or refractory diffuse large b-cell lymphoma talacotuzumabmabhumanizedcd123leukemia etc. talizumabmabhumanizedigeallergic reaction talquetamabbsabhumangprc5d, cd3relapsed or refractory multiple myeloma tamtuvetmabtactressmabveterinarycd52 tanezumabmabhumanizednerve growth factor (ngf)pain taplitumomab paptoxmabmousecd19cancer tarextumabmabhumannotch receptorcancer tavolimabmabchimeric/humanizedcd134cancer teclistamabtecvaylibsabhumanb-cell maturation